Name | Number of supported studies | Average coverage | |
---|---|---|---|
hepatocyte | 6 studies | 58% ± 23% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
liver | 3 studies | 31% ± 12% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
liver | 100% | 22382.36 | 226 / 226 | 99% | 285.78 | 400 / 406 |
pancreas | 95% | 73.56 | 311 / 328 | 63% | 7.81 | 112 / 178 |
brain | 94% | 62.07 | 2491 / 2642 | 12% | 0.21 | 87 / 705 |
muscle | 99% | 84.35 | 792 / 803 | 0% | 0 | 0 / 0 |
lung | 52% | 12.72 | 302 / 578 | 27% | 1.83 | 312 / 1155 |
kidney | 37% | 5.61 | 33 / 89 | 17% | 6.91 | 150 / 901 |
skin | 15% | 4.69 | 270 / 1809 | 34% | 11.46 | 159 / 472 |
heart | 44% | 10.53 | 380 / 861 | 0% | 0 | 0 / 0 |
intestine | 22% | 4.10 | 211 / 966 | 15% | 1.81 | 77 / 527 |
stomach | 11% | 1.62 | 38 / 359 | 22% | 3.19 | 62 / 286 |
esophagus | 9% | 1.48 | 131 / 1445 | 19% | 1.73 | 34 / 183 |
peripheral blood | 27% | 57.41 | 251 / 929 | 0% | 0 | 0 / 0 |
adrenal gland | 26% | 3.74 | 67 / 258 | 1% | 0.02 | 2 / 230 |
bladder | 14% | 1.62 | 3 / 21 | 7% | 0.30 | 35 / 504 |
spleen | 21% | 27.92 | 51 / 241 | 0% | 0 | 0 / 0 |
prostate | 16% | 2.83 | 40 / 245 | 1% | 0.04 | 7 / 502 |
uterus | 12% | 1.82 | 20 / 170 | 3% | 0.06 | 12 / 459 |
thymus | 13% | 2.07 | 85 / 653 | 0% | 0.00 | 1 / 605 |
adipose | 11% | 6.75 | 138 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 10% | 1.63 | 130 / 1335 | 0% | 0 | 0 / 0 |
breast | 8% | 2.65 | 37 / 459 | 0% | 0.04 | 3 / 1118 |
ovary | 8% | 1.07 | 14 / 180 | 0% | 0 | 0 / 430 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0008206 | Biological process | bile acid metabolic process |
GO_0006544 | Biological process | glycine metabolic process |
GO_0002152 | Biological process | bile acid conjugation |
GO_0001889 | Biological process | liver development |
GO_0031100 | Biological process | animal organ regeneration |
GO_0006631 | Biological process | fatty acid metabolic process |
GO_0019530 | Biological process | taurine metabolic process |
GO_0006637 | Biological process | acyl-CoA metabolic process |
GO_0006699 | Biological process | bile acid biosynthetic process |
GO_0005777 | Cellular component | peroxisome |
GO_0005829 | Cellular component | cytosol |
GO_0005782 | Cellular component | peroxisomal matrix |
GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
GO_0052816 | Molecular function | long-chain fatty acyl-CoA hydrolase activity |
GO_0047963 | Molecular function | glycine N-choloyltransferase activity |
GO_0052689 | Molecular function | carboxylic ester hydrolase activity |
GO_0052817 | Molecular function | very long-chain fatty acyl-CoA hydrolase activity |
GO_0016746 | Molecular function | acyltransferase activity |
GO_0052815 | Molecular function | medium-chain fatty acyl-CoA hydrolase activity |
GO_0047617 | Molecular function | fatty acyl-CoA hydrolase activity |
GO_0016410 | Molecular function | N-acyltransferase activity |
GO_0033882 | Molecular function | choloyl-CoA hydrolase activity |
GO_0005515 | Molecular function | protein binding |
Gene name | BAAT |
Protein name | Bile acid-CoA:amino acid N-acyltransferase (BACAT) (BAT) (EC 2.3.1.65) (Bile acid-CoA thioesterase) (Choloyl-CoA hydrolase) (EC 3.1.2.27) (Glycine N-choloyltransferase) (Long-chain fatty-acyl-CoA hydrolase) (EC 3.1.2.2) Bile acid-CoA:amino acid N-acyltransferase |
Synonyms | |
Description | FUNCTION: Catalyzes the amidation of bile acids (BAs) with the amino acids taurine and glycine . More than 95% of the BAs are N-acyl amidates with glycine and taurine . Amidation of BAs in the liver with glycine or taurine prior to their excretion into bile is an important biochemical event in bile acid metabolism . This conjugation (or amidation) plays several important biological roles in that it promotes the secretion of BAs and cholesterol into bile and increases the detergent properties of BAs in the intestine, which facilitates lipid and vitamin absorption . May also act as an acyl-CoA thioesterase that regulates intracellular levels of free fatty acids . In vitro, catalyzes the hydrolysis of long- and very long-chain saturated acyl-CoAs to the free fatty acid and coenzyme A (CoASH), and conjugates glycine to these acyl-CoAs . . |
Accessions | ENST00000674791.1 ENST00000621712.2 Q14032 A0A6Q8PF60 ENST00000674909.1 A0A6Q8PHR9 ENST00000395051.4 ENST00000674556.1 ENST00000259407.7 |